Rebekka Pontoppidan Tuxen

Novo Nordisk

Associate Vice President of Technology Development and Innovation, AMSAT

Rebekka Pontoppidan Tuxen is Associate Vice President of the Technology Development & Innovation area within Aseptic Manufacturing Science and Technology at Novo Nordisk, a leading global healthcare company. Novo Nordisk’s purpose is to drive change to defeat serious chronic diseases. Rebekka graduated as M.Sc. Pharm from the Pharmaceutical University of Denmark (now: University of Copenhagen) in 2004 and has a PhD from the University of Copenhagen from 2009.

Rebekka has been with Novo Nordisk for 11 years in various leadership positions within Chemistry Manufacturing and Controls and Manufacturing Science and Technology. As part of her current area of responsibility, she leads the Manufacturing Innovation strategic partnership between Novo Nordisk and the Danish Technical University, DTU, fostering innovation and development in manufacturing through university engagement and external partnerships. She is an established and experienced leader within innovation, development and implementation.

Life Science Integrates
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.